FDA-TRACK: Animal and Veterinary
Subscribe now!
Interested in receiving FDA-TRACK updates in your inbox?
FDA's Center for Veterinary Medicine (CVM) regulates animal drugs, animal devices and animal food under the Federal Food, Drug and Cosmetic Act. CVM protects and promotes the health of humans and animals by ensuring the safety of the American food supply, the safety of animal food and devices, and the safety and effectiveness of animal drugs.
Each FDA-TRACK program area collects, analyzes, and reports performance measures and results. Explore the progress CVM is making towards its key initiatives below:
Center for Veterinary Medicine Key Initiatives
Animal Food Safety
The goal of this initiative is to promote and protect human and animal health by preventing animal food safety problems.
Antimicrobial Stewardship in Veterinary Settings
The goal of this initiative is to foster the judicious use of medically important antimicrobials in animals to slow the development of antimicrobial resistance.
Post-market Drug Safety, Effectiveness, and Quality
The goal of this initiative is to implement a full lifecycle approach in evaluating marketed FDA-approved animal drugs, including animal drugs used in medicated feed, for safety, effectiveness, and quality.
Pre-market Animal Drug Review
The goal of this initiative is to improve access to safe and effective animal drug products.
Emerging Technologies
The goal of this initiative is to develop a risk-based approach to regulate emerging technologies and address the concerns of the general public and other stakeholders.
Compounded Animal Drugs
The goal of this initiative is to develop and implement policies addressing animal drugs compounded from bulk drug substances, which are a category of unapproved drugs.
Animal Drug User Fee Performance Dashboard
The Animal Drug User Fee Act (ADUFA) authorizes FDA (specifically the Center for Veterinary Medicine) to assess and collect fees for new animal drug products. ADUFA provides FDA with resources to enhance the performance and predictability of the new animal drug review process, resulting in the approval of safe and effective animal drug products.
Animal Generic Drug User Fee Performance Dashboard
The Animal Generic Drug User Fee Act (AGDUFA) authorizes FDA (specifically the Center for Veterinary Medicine) to assess and collect fees for generic new animal drug products. AGDUFA provides FDA with resources to enhance the performance and predictability of the generic new animal drug review process, resulting in the approval of safe and effective animal drug products.